Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort studyMaría Salgado, Judith Dalmau, Cristina Gálvez et al.|The Lancet HIV|2024Cited by 25
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Johannes Schetelig, Kristin Zimmer et al.|Bone Marrow Transplantation|2020Cited by 23
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trialKristina Hölig, Johannes Schetelig, Helmuth Schmidt et al.|Bone Marrow Transplantation|2021Cited by 0